The augmented competition for glucose between Treg cells and tumor cells triggers ATM-related DNA damage, which induces the ERK1/2 and p38 pathways, activates the STAT1/3, and upregulates p53-p21-p16, ultimately resulting in the stable withdrawal of T cells from the cell cycle [16,20,57]. Here, MAPK3 is linked to neoplasm.